Spots Global Cancer Trial Database for psma pet
Every month we try and update this database with for psma pet cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA | NCT04319783 | Advanced Prosta... Cancer of Prost... PSA Castrate Resist... | Darolutamide Radiotherapy | 18 Years - | Trans Tasman Radiation Oncology Group | |
| 68Ga-PSMA PET in the Prostate Cancer | NCT04967001 | Prostatic Neopl... Metastases PSMA-PET | PSMA PET | 40 Years - 90 Years | Xijing Hospital | |
| 68Ga-PSMA PET in the Prostate Cancer | NCT04967001 | Prostatic Neopl... Metastases PSMA-PET | PSMA PET | 40 Years - 90 Years | Xijing Hospital | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | NCT06430411 | Prostate Cancer... Prostate Cancer... Prostate Cancer Prostate Neopla... Oligometastatic... Oligometastasis | Radical prostat... Prostate irradi... Surgical metast... Irradiation of ... Abiraterone ace... Enzalutamide Darolutamide Apalutamide Docetaxel Lutetium-PSMA Androgen depriv... | 18 Years - 80 Years | Medical University of Vienna | |
| PSMA-Guided Ablation of the Prostate | NCT06003556 | Prostate Cancer Localized Prost... | PSMA-1007 Posit... | 50 Years - | University of Alberta | |
| Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer | NCT05328505 | Prostate Cancer | Image-guided Ra... | 18 Years - | University Health Network, Toronto | |
| Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 | NCT05622162 | Prostate Cancer 18F- Fluorochol... PSMA PET Radiotherapy Prostatectomy Tumor of Prosta... | Radiopharmaceut... Radiopharmaceut... | 18 Years - | ITEL Telecomunicazioni Srl | |
| Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer | NCT05328505 | Prostate Cancer | Image-guided Ra... | 18 Years - | University Health Network, Toronto | |
| 68Ga-PSMA PET in the Prostate Cancer | NCT04967001 | Prostatic Neopl... Metastases PSMA-PET | PSMA PET | 40 Years - 90 Years | Xijing Hospital | |
| Prostate MRI and Pylarify PSMA PET/CT | NCT05568537 | Prostate Cancer | Pylarify Pifluf... | 18 Years - | William Beaumont Hospitals | |
| PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores | NCT03495427 | Prostate Cancer Recurrent Prost... | F-DCFPyL Inject... PSMA PET | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 | NCT05622162 | Prostate Cancer 18F- Fluorochol... PSMA PET Radiotherapy Prostatectomy Tumor of Prosta... | Radiopharmaceut... Radiopharmaceut... | 18 Years - | ITEL Telecomunicazioni Srl |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
